Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes

Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy has not been assessed adequately in vulnerable older people who exhibit suboptimal responses after primary vaccination series. This observational study, which was carried out by the VIVALDI study based in Engla...

Descripción completa

Detalles Bibliográficos
Autores principales: Tut, Gokhan, Lancaster, Tara, Krutikov, Maria, Sylla, Panagiota, Bone, David, Spalkova, Eliska, Bentley, Christopher, Amin, Umayr, Jadir, Azar, Hulme, Samuel, Kaur, Nayandeep, Tut, Elif, Bruton, Rachel, Wu, Mary Y., Harvey, Ruth, Carr, Edward J., Beale, Rupert, Stirrup, Oliver, Shrotri, Madhumita, Azmi, Borscha, Fuller, Christopher, Baynton, Verity, Irwin-Singer, Aidan, Hayward, Andrew, Copas, Andrew, Shallcross, Laura, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154221/
https://www.ncbi.nlm.nih.gov/pubmed/37118525
http://dx.doi.org/10.1038/s43587-022-00328-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154221/
https://www.ncbi.nlm.nih.gov/pubmed/37118525
http://dx.doi.org/10.1038/s43587-022-00328-3

Ejemplares similares